- Original research
- Open Access
Prehospital volume resuscitation - Did evidence defeat the crystalloid dogma? An analysis of the TraumaRegister DGU® 2002–2012
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine volume 24, Article number: 42 (2016)
Various studies have shown the deleterious effect of high volume resuscitation following severe trauma promoting coagulopathy by haemodilution, acidosis and hypothermia. As the optimal resuscitation strategy during prehospital trauma care is still discussed, we raised the question if the amount and kind of fluids administered changed over the recent years. Further, if less volume was administered, fewer patients should have arrived in coagulopathic depletion in the Emergency Department resulting in less blood product transfusions.
A data analysis of the 100 489 patients entered into the TraumaRegister DGU® (TR-DGU) between 2002 and 2012 was performed of which a total of 23512 patients (23.3 %) matched the inclusion criteria. Volume and type of fluids administered as well as outcome parameter were analysed.
Between 2002 and 2012, the amount of volume administered during prehospital trauma care decreased from 1790 ml in 2002 to 1039 ml in 2012. At the same time higher haemoglobin mean values, higher Quick’s mean values and reduced mean aPTT can be observed. Simultaneously, more patients received catecholamines (2002: 9.2 to 2012: 13.0 %). Interestingly, the amount of volume administered decreased steadily regardless of the presence of shock. Fewer patients were in the need of blood products and the number of massive transfusions (≥10 pRBC) more than halved.
The changes in volume therapy might have reduced haemodilution potentially resulting in an increase of the Hb value. During the period observed transfusion strategies have become more restrictiveand ratio based; the percentage of patients receiving MT halved as blood products may imply negative secondary effects. Furthermore, preventing administration of high blood product ratios result in less impairment of coagulation factors and inhibitors and an therfore improved coagulation.
The volume administered in severely injured patients decreased considerably during the last decade possibly supporting beneficial effects such as minimizing the risk of coagulopathy and avoiding potential harmful effects caused by blood product transfusions. Despite outstanding questions in trauma resuscitation, principle evidence merges quickly into clinical practice and algorithms.
Volume administration is one of the first therapeutic options in trauma care. While in 1993 Schwab and colleagues  already adapted the US Navy expression ‘damage control’ to trauma surgery, the administration of a significant amount of crystalloids was still common practice . The benefits of delayed fluid resuscitation in hypotensive, bleeding patients were shown to improve patients’ outcome . Subsequently, deleterious effects of excess crystalloid, such as abdominal compartment syndrome, acute respiratory distress syndrome or multiple organ failure (MOF), aroused attention [4, 5]. Non-indicated enhanced volume replacement therapy had furthermore been reported to be associated with increased mortality [6, 7].
At the same time the early posttraumatic coagulopathy has been recognized as an independent entity due to its high incidence at the time of emergency department (ED) admission [8–11]. In addition to endogenous triggers such as tissue trauma, inflammation and endothelial dysfunction, exogenous and iatrogenic factors like uncritical volume administration which contributes to acidosis and hypothermia (“vicious circle”) were described to enhance blood clotting disorder massively .
In order to reduce the amount of crystalloids, colloids were commonly administered in the treatment of haemorrhagic or septic shock. However, negative side effects such as acute kidney injury and impaired coagulation were observed . Therefore, even after haemorrhage, the indication for colloids is questioned while the European medicines agency’s Pharmacovigilance Risk Assessment Committee (PRAC) inferred from recent studies that hydroxyethyl starch solutions (HES) must no longer be used to treat patients with sepsis or critically illness [14, 15]. However, hypertonic solutions are safe but do not show any benefits compared to crystalloids [16, 17].
The increasing awareness of the adverse effects of an incautious volume therapy has led to more restrained recommendations regarding volume replacement in pre-hospital care. Therefore, damage control principles were developed targeting a rapid control of surgical bleeding, an early use of red blood cells (RBC) and plasma, the limitation of excessive crystalloid use and permissive hypotension .
In the present study, the question is raised whether the academic awareness “doing more with less” has led to a reduced prehospital volume administration with balanced electrolyte solutions and colloids in the course of the last decade (2002–2012). Furthermore, it is investigated if an altered volume management has improved coagulation parameters of seriously injured patients and if consecutively less blood products with its potentially harmful effects such as single or multiple organ failure have been required.
The TraumaRegister DGU®
The TraumaRegister DGU® of the German Trauma Society (Deutsche Gesellschaft für Unfallchirurgie, DGU) was founded in 1993. The aim of this multi-centre database is an anonymous and standardized documentation of severely injured patients.
Data are collected prospectively in four consecutive time phases from the site of the accident until dis-charge from hospital: A) Pre-hospital phase, B) Emergency room and initial surgery, C) Intensive care unit and D) Discharge. The documentation includes detailed information on demographics, injury pattern, comorbidities, pre- and in-hospital management, course on intensive care unit, relevant laboratory findings including data on transfusion and outcome of each individual. The inclusion criterion is admission to hospital via emergency room with subsequent ICU/ICM care or reaching the hospital with vital signs and death before admission to ICU.
The infrastructure for documentation, data management, and data analysis is provided by the AUC - Academy for Trauma Surgery (AUC - Akademie der Unfallchirurgie GmbH), a company affiliated to the German Trauma Society. The scientific leadership is provided by the Committee on Emergency Medicine, Intensive Care and Trauma Management (Sektion NIS) of the German Trauma Society. The participating hospitals submit their data anonymously into a central database via a web-based application. Scientific data analysis is approved according to a peer review procedure established by Sektion NIS.
The participating hospitals are primarily located in Germany (90 %), but a rising number of foreign hospitals of other countries contribute data as well (at the moment from Austria, Belgium, China, Finland, Luxembourg, Slovenia, Switzerland, The Netherlands, and the United Arab Emirates). Currently, approx. 25,000 cases from more than 600 hospitals are yearly entered into the database.
Participation in TraumaRegister DGU® is voluntary. For hospitals associated with TraumaNetzwerk DGU®, however, the entry of at least a basic data set is obligatory for quality assurance.
The present study is in line with the publication guidelines of the TraumaRegister DGU® and registered as TR-DGU project ID 2013-057.
In this study, only patients from Germany were included in order to exclude variations in pre-hospital emergency and rescue systems among different countries. A full list of participating hospitals contributing to the TR-DGU can be found at www.traumaregister-dgu.de. All patients admitted were seen and treated by an emergency physician prior to hospital admission.
nclusion criteria for this analysis were as follows:
Age ≥ 18 years
ISS (Injury Severity Score) ≥ 16 points
Primary admission to the hospital (transfers excluded)
Standard documentation data record TR-DGU®
Hospitals participation for 5 or more years
Of the 100.489 patients entered into the data bank of the TR-DGU 2002–2012, a total of 23512 (23.4 %) matched with the inclusion criteria. The remaining numbers were excluded due to hospital transfers (n = 10989; 10.3 %), minor injuries (n = 42735; 42.5 %), injured children below 18 years (n = 1761; 1.72 %), data points that were edited into the short TR-DGU form (n = 15260; 15.2 %), TR-DGU participation for less than 5 years (n = 2132; 2.5 %), absence (n = 1328; 1.3 %) or unknown attendance (n = 1240; 1.2 %) of an emergency physician prior admission to the hospital and missing values for administered fluids and/or the red blood cells (RBCs) (n = 1532; 1.5 %). Similar to previous publications derived from the TR-DGU, shock is defined as systolic blood pressure less or equal (≤) 90 mmHg. Massive transfusion (MT) is specified as more or equal than 10 units of transfused RBCs until ICU admission. Ringer’s solution or 0.9 % NaCl are documented as crystalloid solutions; HES is documented as colloidal solution and HyperHES as hyperoncotic solution. Haemostatic drug therapy in the Emergency Department (ED) was documented since 2005; previous data are also not available for aPTT. Haemostatic drug therapy was defined as the following: administration of Factor VII, Prothrombin Complex Concentrate (PCC/PPSB), Fibrinogen and Tranexamic Acid.
Continuous and categorical values were calculated as overall values for the whole time period and separately for each year. If not presented graphically for each year, overall values are reported together with the first (2002) and the last (2012) value, or with the range (minimum - maximum) of yearly values. This retrospective analysis has a descriptive character. Formal statistical testing comparing all 11 years was avoided since even minor differences would result in highly significant results, due to the large sample size per year. However, in order to analyze potential trends and to estimate yearly changes, repeated linear regression analyses have been performed where the variable of interest was the dependent (i.e. predicted) variable, and the year of observation was the independent (i.e. the predictor) variable. The regression coefficient calculated for each year could then be interpreted as the approximate change per year. The p-value of this coefficient is presented as well. Interpretation of these results have to consider that this approach assumes a constant change over the time period considered which is not always the case.
We did not restrict our analysis to major bleeding cases since the application of volume has been used very deliberately in Germany, and prophylactic use of volume administration has been considered an easy and effective support of severely injured patients. Volume was given to at least 95 % of registry patients in the prehospital phase. The average annual values and their parallel increase or decrease over time are just observed associations, there is no proof of causality. A formal proof of the volume effect on lab values and transfusion rates would require a randomized trial. However, these measurements were made within a short period of time within each patient, on average within less than 1 h regarding initial lab values, and 2–3 h regarding transfusion. This would not allow to assume independence of the measurements. However, the degree of causation remains a matter of interpretation.
Data were analysed using SPSS statistical software package (Version 21, IBM Inc., Armonk, NY, U.S.A.)
A total of 23512 patients from the TR-DGU® met the inclusion criteria for further analysis. General demographics and injury description as well as their respective changes per year are shown in Table 1. While most of the trauma mechanisms did not differ during the observation period, motor vehicle accidents (MVA) decreased from 40.4 % in 2002 to 29.7 % in 2012 whereas low falls (<3 m) increased from 6.7 to 11.9 %. The proportion of severe head injuries (AIS head ≥3) remained constant while severe abdominal injuries (AIS abdomen ≥3) occurred significantly less often (Table 1). The mean ISS was 29 points and did not change over 11 years, while the NISS increased slightly (Table 1). On scene, fewer patients were in shock (23.1 % in 2002 vs. 17.3 % in 2012) while the number of patients in shock admitted to ED remained constant (Fig. 1).
The analysis of the prehospital volume administration between 2002 and 2012 showed that 22575 patients (96.0 %; min - mix 95.0–96.9 %) received prehospital intravenous (i.v.) fluids by the emergency physician. If volume was given, most patients (n = 22110; 97.9 %) received crystalloids. The use of colloids and hyperoncotic solutions, which were usually given in combination with crystalloids, decreased drastically over time (colloids: 69.6 % in 2002 to 28.5 % in 2012; hyperoncotic fluids: 16.4 % in 2002 to 6.0 % in 2012). In contrast, the number of patients receiving crystalloids stayed constantly high (range 96.6 to 98.8 %) in the period presented. The mean volume administered per year subdivided into fluid types, respectively, is shown in Fig. 2a and Table 1.
The average amount of total volume administered decreased from 1790 ml to 1039 ml (Fig. 2a). Comparing the amount of volume administered to patients with and without shock, a steady decrease can be observed in both groups (Fig. 2b). As expected, more volume was administered to patients in shock. Similar to the trend of reduced prehospital volume administration, the volume administered in the ED dropped from 3191 ml in 2002 to 1416 ml in 2012.
Over the time observed, the rate of trauma patients who received prehospital catecholamines inclined from 9.2 to 13.0 %. The proportion of patients receiving catecholamines at the ED stayed constantly around 30 %. At the same time, fewer patients received RBCs (38.7 % in 2002 vs. 20.6 % in 2012; Fig. 3). If transfused, the number of RBC units administered decreased per patient by -0.22 units per year (9.8 RBCs in 2002 vs. 7.6 in 2012). In contrast units of fresh frozen plasma (FFPs) were given to an equal extent, mirroring nearly a 1:1 RBC:FFP ratio in 2012 (6,7 FFP in 2002 vs. 6,1 FFP in 2012). The lowered administration of blood products was further accompanied with less MT that even more than halved (13.4 % in 2002 vs. 5.2 % in 2012). Haemoglobin and Quick’s values increased at admission and the abnormality of the mean Base Excess (BE) declined (Fig. 4). Since the start of recording in 2005, there is a steady rise in the use of haemostatic medication from 10.3 to 18.3 %.
Although it is well known and taught among emergency personnel that factors such as age >80 years, ISS ≥16, GCS <8, hypotension and excessive administration of i.v. fluids promote patients mortality,  it has not been proven if evidence obtains clinical practice.
The period analysed in the present study includes the point in time when rising interest and understanding among experts in the role of hypothermia, coagulopathy and acidosis aroused [4, 5]. Since uncritical volume administration was identified to enhance this vicious circle, a steady decrease of the administered volume after severe trauma can be observed in both, the prehospital use and in ED.
Collecting data in a databank such as the TR-DGU® enables analysis of trauma cases and therapeutic strategies accordingly. As expected with an aging society, patients enclosed in this study grew 0.83 years older per year on average for the timeframe observed, which might at the same time explain the increased rate of low falls below three meters. Improved road safety results in a lower percentage of major road accidents. Nevertheless, also the number of high falls of more than three meters height increased in the period observed. Despite these changes in injury mechanisms, the mean ISS and NISS stayed consistently high and could therefore not cause these differences in volume management. A higher number and a higher severity of injuries of the extremities and pelvis might equalize the decrease of AIS abdomen.
During the last years the evidence even more mounted that aggressive crystalloid administration rather causes a worsening acidosis, may trigger an early inflammatory response, and also entails an substantial increase in morbidity such as Acute Respiratory Distress Syndrome (ARDS), MOF, compartment syndromes and surgical site infections [20, 21]. Although there is less doubt about i.v. fluid administration in trauma patients to maintain tissue perfusion, there is no evidence about any volume threshold for trauma patients . Among others,  the PROMMTT Study Group showed that pre-hospital fluid administration is not associated with increased systolic blood pressure but decreases in-hospital mortality . In contrast, Geeraedts et al. described, that in a cohort of hypotensive trauma patients, prehospital volume therapy was associated with a decrease of the likelihood of shock defined as shock index ≥ 1 . Interestingly, patients in this study received decisively less volume (median, min to max: 0.5 L, 0–8.1 L) compared to our data. The difference might be caused by the fact that Geeraedts et al. included all hypotensive trauma patients, regardless of the injury severity. However, this study underlies the importance of cautious pre-hospital volume replacement.
Furthermore, HAES should not be used in most cases except therapy refractory haemorrhagic shock and possibly penetrating trauma due to less renal affection and decreased lactate levels . Unfortunately, information about the type and concentration of Hydroxyethyl starch are not available, in order to accomplish a more detailed analysis. However, according to the recommendations, we can clearly file the reduced over all use in our data. In comparison of the three different fluids administered the most notable reduction can be seen in colloids.
Although fewer patients were in shock on scene and the prehospital treatment differed decisively, the rate of patients in shock remained steady by the time of arrival at the ED. However, improved BE at the time of admission at ED might indicate a better tissue perfusion despite unaltered low BP. Apparently the decrease in volume administered was potentially compensated by catecholamines given to a greater extend. In trauma patients, the administration of catecholamines recruits unstressed blood volume and might maintain blood pressure . But despite numerous arguments in favour of early vasopressor use, there is still a lack of evidence derived from prospective studies . Some authors even associate vasopressor exposure with an increased mortality [29, 30]. Since catecholamines might influence the presented data masking a true intravascular volume deficit,  we observed indeed a reduced extend of hypovolemic shock, mirrored by the reduced BE by the time of emergency admission . However, the continuous reduction of BE interferes with the unaltered rate of patients with systolic blood pressure below 90 mmHg. Although Eastridge et al. showed that mortality starts to increase with a systolic BP below 110mmHG in patients without brain injury, we defined shock as a BP below or equal 90 mmHg in order to include patients in severe shock . The question remains, if the definition of shock using solely the systolic blood pressure is applicable in this study, although BE values are usually not compiled preclinical.
As described in the current literature, inadequate volume administration and endogenous factors such as tissue hypoperfusion, inflammation and the acute activation of the neurohumoral system contribute to coagulopathy . Although it has been described that crystalloids given even increase thrombin generation  and that low quick values are not necessarily attend with diminished thrombin generation , minimizing the iatrogenic contribution to the development of a TIC might have resulted in a higher Quick’s value and shortened aPTT.
Furthermore, the use of haemostatic drugs increased within the observation period. The administration of Tranexamic Acid (TXA) within 3 h after injury significantly reduced the all-cause mortality and in particular due to bleeding . Subsequently, an early prehospital use of TXA is already recommended in the updated European guidelines . Nevertheless, benefits of prehospital administration of TXA are widely lacking but a prospective, blinded study is currently underway. The study design was recently published scrutinizing this issue .
A further target to avoid coagulopathy is discussed by substitution of fibrinogen as fibrinogen depletes early after trauma. The effect of prehospital fibrinogen concentrate administration is the subject of an on-going prospective investigation . Since the results of these studies might support the prehospital use of both, fibrinogen and TXA, the administration of haemostatic drugs is likely to incline within the next years.
The changes observed in volume therapy might have reduced haemodilution potentially resulting in an increase of the Hb value, which might explain that in 2012 the number of patients receiving blood products halved in comparison to 2002. Correspondingly the percentage of patients receiving MT halved. Already Geeraedts et al. showed, that the likelihood of receiving blood transfusion increases dramatically associated with increasing prehospital volume . Thereby, the development during the last years is certainly along the right lines to avoid mass transfusions as blood products may imply negative secondary effects, such as single or multiple organ failure and sepsis [39, 40]. Besides volume administration, the decreasing rate of MT has multiple reasons. Transfusion strategies have become more restrictive and ratio based to avoid over transfusion and diminish negative effects caused by blood products [41, 42]. Furthermore the updated European guidelines recommend a target-haemoglobin of not more than 7 to 9 g/dl (1c) . In addition, high blood product ratios result in dilution of coagulation factors and inhibitors, prolonged PTT and increased INR and reduced functional coagulation in viscoelastic testing . The quantity of RBCs and FFPs transfused nearly approached a 1:1 ratio, which reflects principles of damage control resuscitation  and the recommendations of the current European guidelines . However, the amount of FFPs transfused only declined slightly.
Certainly as this study is a retrospective register analysis, there are limitations such as susceptibility to observer bias, bias because of selective survival information, incomplete or inaccurate information and dependency on respondents. Therefore, only associations and no causalities can be derived from the underlying data. Still, the TR-DGU® enables illustration of consistency or changes in therapy or therapeutically actions.
The volume administered in severely injured patients decreased considerably during the period observed. In addition to an increased use of haemostatic drugs and goal directed transfusion protocols the need for transfusion is likely to decline further. Although having identified principal drivers of coagulopathy and implementing evidence based algorithms, it still remains unclear, which basic amount of pre-hospital volume therapy is needed. Therefore, subsequent research is inevitable. Despite outstanding questions, principle evidence in volume management has rapidly merged into clinical practice and algorithms during the last years.
Deutsche Gesellschaft für Unfallchirurgie (German Trauma Society)
massive transfusion protocol
motor vehicle accident
European medicines agency’s Pharmacovigilance Risk Assessment Committee
packed red blood cells
fresh frozen plasma
activated partial thromboplastin time
Prothrombin Complex Concentrate
trauma induced coagulopathy
Rotondo MF, Schwab CW, McGonigal MD, Phillips GR, Fruchterman TM, Kauder DR, Latenser BA, Angood PA. Damage control“: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma. 1993;35:375–82. discussion 382–3.
Moore FA, McKinley BA, Moore EE. The next generation in shock resuscitation. Lancet. 2004;363:1988–96.
Bickell WH, Wall MJ, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331:1105–9.
Cotton BA, Guy JS, Morris JA, Abumrad NN. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock. 2006;26:115–21.
Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, de Boisblanc B, Connors AF, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–75.
Hussmann B, Lefering R, Waydhas C, Touma A, Kauther MD, Ruchholtz S, Lendemans S. Does increased prehospital replacement volume lead to a poor clinical course and an increased mortality? A matched-pair analysis of 1896 patients of the Trauma Registry of the German Society for Trauma Surgery who were managed by an emergency doctor at th. Injury. 2013;44:611–7.
Hussmann B, Lefering R, Kauther MD, Ruchholtz S, Moldzio P, Lendemans S. Influence of prehospital volume replacement on outcome in polytraumatized children. Crit Care. 2012;16:R201.
Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54:1127–30.
Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A, Hautin E, David JS, Négrier C, Allaouchiche B. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2012;43:26–32.
MacLeod JBA, Lynn M, McKenney MG, Cohn SM, Murtha M. Early Coagulopathy Predicts Mortality in Trauma. J Trauma Inj Infect Crit Care. 2003;55:39–44.
Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, Simanski C, Neugebauer E, Bouillon B. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;38:298–304.
Wafaisade A, Wutzler S, Lefering R, Tjardes T, Banerjee M, Paffrath T, Bouillon B, Maegele M. Drivers of acute coagulopathy after severe trauma: a multivariate analysis of 1987 patients. Emerg Med J. 2010;27:934–9.
Heuer M, Hussmann B, Lefering R, Kaiser GM, Eicker C, Guckelberger O, Lendemans S. Prehospital fluid management of abdominal organ trauma patients--a matched pair analysis. Langenbecks Arch Surg. 2015;400(3):371-9. doi:10.1007/s00423-015-1274-2. Epub 2015 Feb 14.
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SAR. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–11.
Perner A, Haase N, Winkel P, Guttormsen AB, Tenhunen J, Klemenzson G, Müller RG, Aneman A, Wetterslev J. Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer’s acetate. Intensive Care Med. 2014;40:927–34.
Bulger EM, May S, Brasel KJ, Schreiber M, Kerby JD, Tisherman SA, Newgard C, Slutsky A, Coimbra R, Emerson S, Minei JP, Bardarson B, Kudenchuk P, Baker A, Christenson J, Idris A, Davis D, Fabian TC, Aufderheide TP, Callaway C, Williams C, Banek J, Vaillancourt C, Heest R, Sopko G, Hata JS, Hoyt DB. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA. 2010;304:1455–64.
Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent J-L, Rossaint R. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care. 2013;17:R76.
Miller TE. New evidence in trauma resuscitation - is 1:1:1 the answer? Perioper Med (London, England). 2013;2:13.
Ley EJ, Clond MA, Srour MK, Barnajian M, Mirocha J, Margulies DR, Salim A. Emergency department crystalloid resuscitation of 1.5 L or more is associated with increased mortality in elderly and nonelderly trauma patients. J Trauma. 2011;70:398–400.
Kasotakis G, Sideris A, Yang Y, de Moya M, Alam H, King DR, Tompkins R, Velmahos G. Aggressive early crystalloid resuscitation adversely affects outcomes in adult blunt trauma patients: an analysis of the Glue Grant database. J Trauma Acute Care Surg. 2013;74:1215–21. discussion 1221–2.
Maegele M, Schöchl H, Cohen MJ. An Up-date on the Coagulopathy of Trauma. Shock. 2014;41 Suppl 1:21-5. doi:10.1097/SHK.0000000000000088.
Aksu U, Bezemer R, Yavuz B, Kandil A, Demirci C, Ince C. Balanced vs unbalanced crystalloid resuscitation in a near-fatal model of hemorrhagic shock and the effects on renal oxygenation, oxidative stress, and inflammation. Resuscitation. 2012;83:767–73.
Schreiber MA, Meier EN, Tisherman SA, Kerby JD, Newgard CD, Brasel K, Egan D, Witham W, Williams C, Daya M, Beeson J, McCully BH, Wheeler S, Kannas D, May S, McKnight B, Hoyt DB. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: Results of a prospective randomized pilot trial. J Trauma Acute Care Surg. 2015;78:687–97.
Hampton DA, Fabricant LJ, Differding J, Diggs B, Underwood S, De La Cruz D, Holcomb JB, Brasel KJ, Cohen MJ, Fox EE, Alarcon LH, Rahbar MH, Phelan HA, Bulger EM, Muskat P, Myers JG, Junco DJ, Wade CE, Cotton BA, Schreiber MA. Prehospital intravenous fluid is associated with increased survival in trauma patients. J Trauma Acute Care Surg. 2013;75(1 Suppl 1):S9–15.
Geeraedts LMG, Pothof LAH, Caldwell E, Klerk ESMDL, Amours SKD. Prehospital fluid resuscitation in hypotensive trauma patients : Do we need a tailored approach ? Injury. 2015;46:4–9.
Ogilvie MP, Pereira BMT, McKenney MG, McMahon PJ, Manning RJ, Namias N, Livingstone AS, Schulman CI, Proctor KG. First report on safety and efficacy of hetastarch solution for initial fluid resuscitation at a level 1 trauma center. J Am Coll Surg. 2010;210:870–80. 880–2.
Giraud R, Siegenthaler N, Arroyo D, Bendjelid K. Impact of epinephrine and norepinephrine on two dynamic indices in a porcine hemorrhagic shock model. J Trauma Acute Care Surg. 2014;77:564–9. quiz 650–1.
Beloncle F, Meziani F, Lerolle N, Radermacher P, Asfar P. Does vasopressor therapy have an indication in hemorrhagic shock? Ann Intensive Care. 2013;3:13.
Sperry JL, Minei JP, Frankel HL, West MA, Harbrecht BG, Moore EE, Maier RV, Nirula R. Early use of vasopressors after injury: caution before constriction. J Trauma. 2008;64:9–14.
Plurad DS, Talving P, Lam L, Inaba K, Green D, Demetriades D. Early vasopressor use in critical injury is associated with mortality independent from volume status. J Trauma. 2011;71:565–70. discussion 570–2.
Nouira S, Elatrous S, Dimassi S, Besbes L, Boukef R, Mohamed B, Abroug F. Effects of norepinephrine on static and dynamic preload indicators in experimental hemorrhagic shock. Crit Care Med. 2005;33:2339–43.
Mutschler M, Nienaber U, Münzberg M, Wölfl C, Schoechl H, Paffrath T, Bouillon B, Maegele M. The Shock Index revisited - a fast guide to transfusion requirement? A retrospective analysis on 21,853 patients derived from the TraumaRegister DGU®. Crit Care. 2013;17:R172.
Eastridge BJ, Salinas J, McManus JG, Blackburn L, Bugler EM, Cooke WH, Convertino VA, Concertino VA, Wade CE, Holcomb JB. Hypotension begins at 110 mm Hg: redefining “hypotension” with data. J Trauma. 2007;63:291–7. discussion 297–9.
Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion. 2009;49:2652–60.
Ruttmann TG, Jamest MF, Lombard EH. Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care. 2001;29:489–93.
Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero M-A, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.
Brown JB, Neal MD, Guyette FX, Peitzman AB, Billiar TR, Zuckerbraun BS, Sperry JL. Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: Addressing the Knowledge Gaps. Prehosp Emerg Care. 2014;19:79–86.
Schöchl H, Schlimp CJ, Maegele M. Tranexamic acid, fibrinogen concentrate, and prothrombin complex concentrate: data to support prehospital use? Shock. 2014;41 Suppl 1:44–6.
Wafaisade A, Lefering R, Bouillon B, Sakka SG, Thamm OC, Paffrath T, Neugebauer E, Maegele M. Epidemiology and risk factors of sepsis after multiple trauma: an analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery. Crit Care Med. 2011;39:621–8.
Fröhlich M, Lefering R, Probst C, Paffrath T, Schneider MM, Maegele M, Sakka SG, Bouillon B, Wafaisade A. Epidemiology and risk factors of multiple-organ failure after multiple trauma: an analysis of 31,154 patients from the TraumaRegister DGU. J Trauma Acute Care Surg. 2014;76:921–7. discussion 927–8.
Hallet J, Lauzier F, Mailloux O, Trottier V, Archambault P, Zarychanski R, Turgeon AF. The Use of Higher Platelet: RBC Transfusion Ratio in the Acute Phase of Trauma Resuscitation: A Systematic Review. Crit Care Med. 2013;41(12):2800-11. doi:10.1097/CCM.0b013e31829a6ecb.
Callum JL, Rizoli S. Plasma transfusion for patients with severe hemorrhage: what is the evidence? Transfusion. 2012;52 Suppl 1:30S–7.
Driessen A, Schäfer N, Bauerfeind U, Kaske S, Fromm-Dornieden C, Stuermer EK, Maegele M. Functional capacity of reconstituted blood in 1:1:1 versus 3:1:1 ratios: A thrombelastometry study. Scand J Trauma Resusc Emerg Med. 2015;23:2.
Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon’s perspective. Hematol Am Soc Hematol Educ Program. 2013;2013:656–9.
the TraumaRegister DGU: Committee on Emergency Medicine, Intensive Care and Trauma Management of the German Trauma Society (Sektion NIS).
The authors declare that they have no competing interests.
AD, MF, NS and MMa designed the study. RL analysed the data which AD, MF, MMu, BB and MMa interpreted. AD and MF performed the literature review and wrote the manuscript. MMu, MMa, JD, TB and BB were providing scientific support and valuable advice working on the manuscript. AD, MM, NS, MMu, TB, ES, RL and DJ were proof reading the manuscript, revising it critically and providing generous technical support with figures and tables. All authors have read and approved the final manuscript.
About this article
Cite this article
Driessen, A., Fröhlich, M., Schäfer, N. et al. Prehospital volume resuscitation - Did evidence defeat the crystalloid dogma? An analysis of the TraumaRegister DGU® 2002–2012. Scand J Trauma Resusc Emerg Med 24, 42 (2016) doi:10.1186/s13049-016-0233-4
- Pre-hospital volume administration
- Massive transfusion
- Hyperoncotic fluids
- Trauma care